Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Respirerx Pharmaceuticals Inc (RSPI)

Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Respirerx Pharmaceuticals Inc 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 USA

www.respirerx.com P: 201-444-4947

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company which focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain- mediated breathing disorders. The company's drug platforms comprises of ampakines for positive allosteric modulators of AMPA glutamate receptors and cannabinoids, primarily dronabinol, a synthetic derivative for use in refractory chemotherapy-induced nausea and vomiting as well as for anorexia. RespireRx Pharmaceuticals Inc. is based in Glen Rock, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 1,709
Enterprise Value, $K 1,729
Shares Outstanding, K 949,464
Annual Sales, $ 0 K
Annual Net Income, $ -2,100 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -400 K
EBIT, $ -1,410 K
EBITDA, $ -1,020 K
60-Month Beta 0.19
% of Insider Shareholders 50.03%
% of Institutional Shareholders 0.00%
Float, K 474,447
% Float 49.97%
Short Interest 0
Short Float 0.00%
Short Volume Ratio 1.00

Growth:

1-Year Return 125.00%
3-Year Return -65.38%
5-Year Return -95.50%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm -0.02
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/06/21

RSPI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.04
Interest Coverage -2.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar